"10.1371_journal.pone.0088621","plos one","2014-02-18T00:00:00Z","Otto O Yang; F Javier Ibarrondo; Charles Price; Lance E Hultin; Julie Elliott; Patricia M Hultin; Roger Shih; Mary Ann Hausner; Hwee L Ng; Jennifer Hoffman; Beth D Jamieson; Peter A Anton","Department of Medicine and University of California Los Angeles AIDS Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America; AIDS Healthcare Foundation, Los Angeles, California, United States of America","Conceived and designed the experiments: OY FI JE BJ PA. Performed the experiments: FI LH JE PH RS MH HN. Analyzed the data: OY FI LH JE JH BJ PA. Contributed reagents/materials/analysis tools: CP PA. Wrote the paper: OY FI JH BJ PA. Clinical trial administrative management: CP.","Sanofi Pasteur specifically provided the GMP vaccine and placebo, and performed the ELISAs for anti-Canarypox antibodies. Otherwise, they provided no financial support related to this study. Requests for vCP205 vaccine and canarypox ELISA reagents would need to be directed to Sanofi Pasteur, but otherwise this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","02","Otto O Yang","OOY",12,TRUE,5,7,7,5,TRUE,TRUE,FALSE,0,NA,FALSE
